What is the actual epidemiology of familial hypercholesterolemia in Italy? Evidence from a National Primary Care Database-Reference-Cited by-同舟云学术

What is the actual epidemiology of familial hypercholesterolemia in Italy? Evidence from a National Primary Care Database

Published:2016-11 Issue: Volume:223 Page:701-705
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Guglielmi Valeria,Bellia Alfonso,Pecchioli Serena,Medea Gerardo,Parretti Damiano,Lauro Davide,Sbraccia Paolo,Federici Massimo,Cricelli Iacopo,Cricelli Claudio,Lapi Francesco

Funder

Italian College of General Practitioners and Primary Care

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. Mechanisms of disease: genetic causes of familial hypercholesterolemia;Soutar;Nat. Clin. Pract. Cardiovasc. Med.,2007

2. What is the clinical utility of DNA testing in patients with familial hypercholesterolaemia?;Humphries;Curr. Opin. Lipidol.,2008

3. Effects of atorvastatin on serum lipids of patients with familial hypercholesterolaemia;Hoogerbrugge;J. Intern. Med.,1998

4. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society;Nordestgaard;Eur. Heart J.,2013

5. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society;Cuchel;Eur. Heart J.,2014

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus document on diagnosis and management of familial hypercholesterolemia from the Italian Society for the Study of Atherosclerosis (SISA);Nutrition, Metabolism and Cardiovascular Diseases;2024-08

2. A methodology to assess the population size and estimate the needed resources for new licensed medications by combining clinical and administrative databases: The example of glycated haemoglobin in type 2 diabetes;Pharmacoepidemiology and Drug Safety;2023-05-29

3. How many and who are patients with heart failure eligible to SGLT2 inhibitors? Responses from the combination of administrative healthcare and primary care databases;International Journal of Cardiology;2023-01

4. To clarify the safety profile of paracetamol for home-care patients with COVID-19: a real-world cohort study, with nested case–control analysis, in primary care;Internal and Emergency Medicine;2022-07-30

5. Screening and treatment of familial hypercholesterolemia in a French sample of ambulatory care patients: A retrospective longitudinal cohort study;PLOS ONE;2021-08-02